| The effect of performance-volume limit on the DRG based acute care hospital financing in Hungary D Endrei, A Zemplényi, B Molics, I Ágoston, I Boncz Health Policy 115 (2-3), 152-156, 2014 | 75 | 2014 |
| Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer AT Zemplényi, Z Kaló, G Kovács, R Farkas, T Beöthe, D Bányai, ... European Journal of Cancer Care 27 (1), e12430, 2018 | 74 | 2018 |
| Direct healthcare cost of schizophrenia–European overview G Kovács, T Almási, A Millier, M Toumi, M Horváth, K Kóczián, Á Götze, ... European Psychiatry 48 (1), 79-92, 2018 | 65 | 2018 |
| Surrogate endpoints in health technology assessment: an international review of methodological guidelines B Grigore, O Ciani, F Dams, C Federici, S de Groot, M Möllenkamp, ... Pharmacoeconomics 38 (10), 1055-1070, 2020 | 57 | 2020 |
| The patient at the centre: evidence from 17 European integrated care programmes for persons with complex needs T Czypionka, M Kraus, M Reiss, E Baltaxe, J Roca, S Ruths, J Stokes, ... BMC health services research 20, 1-14, 2020 | 45 | 2020 |
| Defining good health and care from the perspective of persons with multimorbidity: results from a qualitative study of focus groups in eight European countries FRM Leijten, M Hoedemakers, V Struckmann, M Kraus, S Cheraghi-Sohi, ... BMJ open 8 (8), e021072, 2018 | 37 | 2018 |
| Barriers to use artificial intelligence methodologies in health technology assessment in central and east European countries K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ... Frontiers in Public Health 10, 921226, 2022 | 26 | 2022 |
| Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta … RG Vida, E Sághy, R Bella, S Kovács, D Erdősi, J Józwiak-Hagymásy, ... BMC psychiatry 23 (1), 545, 2023 | 24 | 2023 |
| Cost-effectiveness analysis of invasive EEG monitoring in drug-resistant epilepsy S Kovács, M Tóth, J Janszky, T Dóczi, D Fabó, I Boncz, L Botz, ... Epilepsy & Behavior 114, 107488, 2021 | 23 | 2021 |
| Implementation of palliative care consult Service in Hungary–integration barriers and facilitators AT Zemplényi, Á Csikós, M Csanádi, MR Mölken, C Hernandez, JG Pitter, ... BMC palliative care 19, 1-12, 2020 | 23 | 2020 |
| Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a … JG Pitter, M Csanádi, A Szigeti, G Lukács, Á Kovács, M Moizs, I Repa, ... BMC health services research 19, 1-13, 2019 | 20 | 2019 |
| ápilis 1-i egészségügyi reform intézkedések hatása az összes kórházi ágyszámra G Vas, G Imhof, I Ágoston, B Vas, J Betlehem, G Kresák, D Endrei, ... Egészségügyi gazdasági szemle 47 (4), 5-11, 2009 | 18 | 2009 |
| Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening P Elek, P Fadgyas-Freyler, B Váradi, B Mayer, A Zemplényi, M Csanádi Health Policy 126 (8), 763-769, 2022 | 17 | 2022 |
| Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges R Daubner-Bendes, S Kovács, M Niewada, M Huic, M Drummond, ... Frontiers in public health 8, 612410, 2021 | 17 | 2021 |
| Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study K Ocskay, MF Juhász, N Farkas, N Zádori, L Szakó, Z Szakács, A Szentesi, ... BMJ open 12 (1), e050821, 2022 | 16 | 2022 |
| Regulatory and HTA early dialogues in medical devices CR Blankart, F Dams, H Penton, Z Kaló, A Zemplényi, K Shatrov, ... Health Policy 125 (10), 1322-1329, 2021 | 16 | 2021 |
| Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries A Inotai, T Ágh, AW Karpenko, A Zemplényi, Z Kaló Expert Review of Pharmacoeconomics & Outcomes Research 19 (2), 105-113, 2019 | 16 | 2019 |
| Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment A Zemplényi, K Tachkov, L Balkanyi, B Németh, ZI Petykó, G Petrova, ... Frontiers in Public Health 11, 1088121, 2023 | 15 | 2023 |
| Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder A Zemplényi, J Józwiak-Hagymásy, S Kovács, D Erdősi, I Boncz, T Tényi, ... BMC psychiatry 22 (1), 437, 2022 | 14 | 2022 |
| Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries M Csanádi, Z Kaló, M Rutten-van Molken, W Looman, M Huic, D Ercevic, ... Health Policy 126 (11), 1173-1179, 2022 | 11 | 2022 |
